Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05793684 · ClinicalTrials.gov registry record · Phase 2
AD816 Crossover Study
A Phase 2 study, sponsored by Apnimed.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT05793684 is a Phase 2 study that has completed, run by Apnimed. The registered enrollment target is 25 participants.
The verdict
NCT05793684, a Phase 2 study, has completed, sponsored by Apnimed.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
The VicTor Study is a randomized, double blind, placebo-controlled, 3-period, multiple-dose crossover study in participants with OSA.
Interventions
- DRUG Period A
- DRUG Period B
- DRUG Period C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-04-28 |
| Est. Completion | 2023-11-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05793684
The ClinicalTrials.gov registry entry for NCT05793684 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Apnimed, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Period A is the first listed.
NCT05793684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05793684 about?
NCT05793684 is a clinical study titled "AD816 Crossover Study". The VicTor Study is a randomized, double blind, placebo-controlled, 3-period, multiple-dose crossover study in participants with OSA.
What is the current status of trial NCT05793684?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2023-04-28. Estimated completion is 2023-11-09.
What interventions are being tested in trial NCT05793684?
The interventions under investigation include: Period A (DRUG), Period B (DRUG), Period C (DRUG).
Who is sponsoring clinical trial NCT05793684?
This trial is sponsored by Apnimed, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.